14
IRUS Total
Downloads
  Altmetric

ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions

File Description SizeFormat 
ERJ-00900-2019.R2_Proof_hi.pdfAccepted version1.09 MBAdobe PDFView/Open
Title: ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Authors: Bourdin, A
Bjermer, L
Brightling, C
Brusselle, GG
Chanez, P
Chung, KF
Custovic, A
Diamant, Z
Diver, S
Djukanovic, R
Hamerlijnck, D
Horvath, I
Johnston, SL
Kanniess, F
Papadopoulos, N
Papi, A
Russell, RJ
Ryan, D
Samitas, K
Tonia, T
Zervas, E
Gaga, M
Item Type: Journal Article
Abstract: Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent serious outcomes such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial healthcare costs and psychological burden, including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a task force to search for a clear definition of severe exacerbations, and to also define research questions and priorities. The statement includes comments from patients who were members of the task force.
Issue Date: 1-Sep-2019
Date of Acceptance: 17-Jul-2019
URI: http://hdl.handle.net/10044/1/81234
DOI: 10.1183/13993003.00900-2019
ISSN: 0903-1936
Publisher: European Respiratory Society
Start Page: 1
End Page: 25
Journal / Book Title: European Respiratory Journal
Volume: 54
Issue: 3
Copyright Statement: ©ERS 2019
Keywords: Science & Technology
Life Sciences & Biomedicine
Respiratory System
NEAR-FATAL ASTHMA
SEVERE EOSINOPHILIC ASTHMA
EXHALED NITRIC-OXIDE
MODIFIABLE RISK-FACTORS
DOSE INHALED CORTICOSTEROIDS
INTERMITTENT BETA-AGONISTS
GENOME-WIDE ASSOCIATION
QUALITY-OF-LIFE
DOUBLE-BLIND
BUDESONIDE-FORMOTEROL
Science & Technology
Life Sciences & Biomedicine
Respiratory System
NEAR-FATAL ASTHMA
SEVERE EOSINOPHILIC ASTHMA
EXHALED NITRIC-OXIDE
MODIFIABLE RISK-FACTORS
DOSE INHALED CORTICOSTEROIDS
INTERMITTENT BETA-AGONISTS
GENOME-WIDE ASSOCIATION
QUALITY-OF-LIFE
DOUBLE-BLIND
BUDESONIDE-FORMOTEROL
11 Medical and Health Sciences
Respiratory System
Publication Status: Published
Article Number: ARTN 1900900
Online Publication Date: 2019-09-28
Appears in Collections:National Heart and Lung Institute
Airway Disease